Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 4/20 | 0.32 |
| ▸ | MAOB | P27338 | 4/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24768833 | 0.95 | ATM (0.36) | TOP2AMAOAMAOBACHEKDM4E | |
| SCHEMBL24767791 | 0.91 | ALOX12 (0.34) | TOP2AMAOAMAOBACHEKDM4E | |
| SCHEMBL17405830 | 0.87 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL16275604 | 0.87 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL24767800 | 0.87 | MAPK10 (0.34) | TOP2A | |
| SCHEMBL24767802 | 0.86 | TOP2A (0.34) | TOP2A | |
| SCHEMBL24767801 | 0.86 | TOP2A (0.34) | TOP2A | |
| SCHEMBL24768830 | 0.85 | CYP17A1 (0.33) | TOP2A | |
| SCHEMBL17405484 | 0.85 | KDM4E (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL16275595 | 0.85 | KDM4E (0.40) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | TOP2A 4331/4885MAOA 395/4885MAOB 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.